Liver Cirrhosis Clinical Trial
Official title:
Associated Balance of Risk Score - Comprehensive Complication Index for the Prediction of Long-term Survival After Liver Transplantation
In recent years, several scoring systems have been developed aimed at predicting early
post-LT graft function. However, many of them showed poor efficacy when long-term survivals
were tested. Moreover, the necessity to find an easy-to-use score represents another
obstacle, with several scores composed by numerous, difficult to find, variables. Recently,
the pre-LT Balance of Risk (BAR) and the post-LT Comprehensive Complication Index (CCI) have
been created, but their external validation and integration in this setting is lacking.
This study aims at constructing an easy-to-use score system based on the combination of a
small number of pre- and immediately post-liver transplant (LT) independent variables, in
order to accurately predict long-term graft survival after LT.
In the last years, several scoring systems have been developed with the intent to predict
waiting-list mortality or early allograft dysfunction (EAD) after liver transplantation (LT).
The Model for End-stage Liver Disease (MELD) is recognised as the most accurate liver
allograft allocation model by prioritising patients according to the severity of their
disease. However, several studies showed that MELD alone failed to predict early and late
post-transplant clinical course. Consequently, other scoring systems based on pre-LT or
post-LT variables have been developed, with the intent to identify high-risk cases for death,
graft loss or re-transplantation (re-LT). Among them, two pre-LT scores, namely the D-MELD
and Balance of Risk (BAR), showed to well predict early post-LT survival. Similarly, some
post-LT scores were able to estimate EAD, and, thereby, to predict the probabilities of early
re-LT and patient death. Interestingly, all of these scores, especially those based on pre-LT
variables, resulted in a scarce prediction of long-term (five-year) survivals.
Recently, the Comprehensive Complication Index (CCI) has been developed in order to better
capture complication rates after surgery. Some reports reported its excellent prognostic
ability in different fields. However, up to now, no studies investigated the role of CCI
concerning long-term prognostication of graft loss in LT.
This study aims at constructing an easy-to-use score system based on the combination of a
small number of pre- and immediately post-LT independent variables, in order to accurately
predict five-year post-LT graft survival. Both external and internal validations of the score
were performed.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04533932 -
Endosonographic Shear Wave Elastography for Liver Stiffness
|
||
Not yet recruiting |
NCT06031740 -
A Comparison of Flexible Endoscopic Polidocanol Liquid and Foam Sclerotherapy in Cirrhotic Patients With Bleeding From Internal Hemorrhoids
|
N/A | |
Not yet recruiting |
NCT06026267 -
Efficacy of Conventional Dose Protocol vs Low Dose Protocol Albumin Use in Patients With Cirrhosis and High Risk Spontaneous Bacterial Peritonitis
|
N/A | |
Not yet recruiting |
NCT06076330 -
Efficacy of 5% Albumin v/s Plasmalyte in Combination With 20% Albumin for Fluid Resuscitation in Cirrhosis With Sepsis Induced Hypotension
|
N/A | |
Enrolling by invitation |
NCT05055713 -
A Randomized Controlled Study on the Treatment of Cirrhosis Combined With Hypersplenism
|
N/A | |
Recruiting |
NCT04578301 -
Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver Disease
|
||
Not yet recruiting |
NCT05120557 -
Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH
|
N/A | |
Not yet recruiting |
NCT05515861 -
Evaluation of EUS in Preventing Rebleeding After Endoscopic Cyanoacrylate Injection for Gastric Varices
|
N/A | |
Not yet recruiting |
NCT03623360 -
Functional MRI to Determine Severity of Cirrhosis
|
||
Not yet recruiting |
NCT02710227 -
Sleep Timing and Circadian Preferences in A Sample of Egyptian Patients With Hepatic Cirrhosis
|
N/A | |
Completed |
NCT02917408 -
Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital
|
||
Active, not recruiting |
NCT02551250 -
Annual MRI Versus Biannual US for Surveillance of Hepatocellular Carcinoma in Liver Cirrhosis
|
||
Recruiting |
NCT02239991 -
Management of Perioperative Coagulopathy With Thromboelastometry (ROTEM) in Liver Transplant
|
N/A | |
Enrolling by invitation |
NCT02256514 -
Open Label Trial of Immunotherapy for Advanced Liver Cancer
|
Phase 2 | |
Terminated |
NCT02311985 -
Comparison of Three Transfusion Strategies for Central Venous Catheterization in Cirrhotics: A Randomized Clinical Trial
|
N/A | |
Terminated |
NCT01937130 -
Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF
|
Phase 2 | |
Recruiting |
NCT01728688 -
Safety and Efficacy of Human Autologous Peripheral Blood Stem Cells for Treatment of HBV-related Liver Cirrhosis
|
Phase 1/Phase 2 | |
Recruiting |
NCT01618890 -
Hepatic Venous Pressure Gradient-guided Versus Standard Beta-blocker Therapy in Primary Prevention of Variceal Bleeding
|
Phase 3 | |
Recruiting |
NCT01724697 -
Safety and Efficacy of Human Bone Marrow Stem Cells for Treatment of HBV-related Liver Cirrhosis
|
Phase 1/Phase 2 | |
Recruiting |
NCT01728727 -
Safety and Efficacy of Human Umbilical Cord Derived Mesenchymal Stem Cells for Treatment of HBV-related Liver Cirrhosis
|
Phase 1/Phase 2 |